Clinical outcome assessment of colistin sulphate in children with carbapenem-resistant organism infections: First data from China.
Xueping YangTao WangBohua ZhangWenting ZhangGuangjie WuDong XuDong LiuYan He
Published in: International journal of antimicrobial agents (2024)
In this real-world setting, CSI demonstrated a high level of clinical response and was well tolerated for the treatment of carbapenem-resistant organism infections in Chinese children.